Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers December 18, 2014
Pharmacy Choice - Pharmaceutical News - FDA rejects petition to remove high Aricept dose - December 18, 2014

Pharmacy News Article

 11/6/12 - FDA rejects petition to remove high Aricept dose

WASHINGTON A consumer group that pressed the Food and Drug Administration to remove the highest dose of an Alzheimer's disease drug from the market says the agency has rejected its request.

Public Citizen said late Tuesday the FDA declined to withdraw the 23-milligram dose of Aricept, made by Japan's Eisai Co. Lt, following a lawsuit filed against the agency.

The consumer advocacy group first petitioned the agency over the drug in May 2011, saying the high dose has more dangerous, potentially deadly side effects including vomiting, which in Alzheimer's patients "can lead to pneumonia, massive gastrointestinal bleeding, esophageal rupture or death." The group asked the FDA to halt sales of the highest dose of Aricept and put safety warnings about the high-dose risks on two lower doses of 5 and 10 milligrams.

In September the group filed a lawsuit in federal court to compel the agency to respond to the petition. The agency denied the request in a letter sent to the group Tuesday.

"Allowing drug manufacturer Eisai to exploit and harm vulnerable patients with Alzheimer's disease is unconscionable," said Dr. Sidney Wolfe, director of Public Citizen's Health Research Group, in a statement.

He noted that Aricept is the best-selling Alzheimer's drug of all time, with sales of $2.4 billion in 2010. Sales have declined since the drug lost patent protection in the U.S.

(c) 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Dec 18: Anticoagulants: The Rapidly Changing Landscape
Last Chance
Dec 19: Is the Patient Comfortable in Their Skin?: Recommendations for Eczema & Dry Skin
Dec 21: Medical Marijuana: Examining the Science, Not the Politics
Dec 22: Update on the Treatment of Schizophrenia
Dec 23: Motivation: The Key to Improving Patient Outcomes
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement